98%
921
2 minutes
20
Alternative polyadenylation results in different 3' isoforms of messenger RNA (mRNA) transcripts. Alternative polyadenylation in the 3' untranslated region (3'UTR) can alter RNA localization, stability and translational efficiency. The SERPINA1 mRNA has two distinct 3' UTR isoforms, both of which express the protease inhibitor α-1-antitrypsin (A1AT). A1AT is an acute phase protein that is expressed and secreted from liver hepatocytes and upregulated during inflammation. Low levels of A1AT in the lung contributes to chronic obstructive pulmonary disease, while misfolding of A1AT in the liver contributes to liver cirrhosis. We analyzed the dynamics of alternative polyadenylation during cellular stress by treating the liver cell line HepG2 with the cytokine interleukin 6 (IL-6), ethanol or peroxide. SERPINA1 is transcriptionally upregulated after IL-6 treatment and has altered polyadenylation, resulting in an increase in long 3'UTR isoforms. We find that the long 3'UTR represses endogenous A1AT protein expression even with high levels of SERPINA1 mRNA. SERPINA1 expression and 3' end processing are not affected by ethanol or peroxide. IL-6-induced changes in transcriptome-wide transcriptional regulation suggest changes to the endoplasmic reticulum and in secretory protein processing. Our data shows that inflammation influences polyA site choice for SERPINA1 transcripts, resulting in reduced A1AT protein expression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12222872 | PMC |
http://dx.doi.org/10.1038/s41598-025-07569-3 | DOI Listing |
BMC Pulm Med
August 2025
Respire - Instituto para el cuidado respiratorio, Santa Marta, Magdalena, Colombia.
Background: Alpha-1 antitrypsin (AAT) is a medium-sized globular glycoprotein distributed in serum and tissues. In the lungs, it inhibits serine proteases and has anti-inflammatory properties in different types of cells, protecting lung tissue from damage. Mutations in the SERPINA1 gene that codes for AAT are related to asthma and chronic obstructive pulmonary disease.
View Article and Find Full Text PDFAnn Saudi Med
August 2025
From the Department of Medical Sciences II, Faculty of Medicine and Health Sciences, Universiti Sains Islam, Nilai, Negeri Sembilan, Malaysia.
Background: Alpha-1 antitrypsin (A1AT) deficiency has been recognized as an adverse prognostic determinant in severe instances of COVID-19.
Objective: To determine the A1AT phenotypes and levels in individuals at various clinical stages of COVID-19 compared to healthy controls.
Design: Case-control study.
Hum Mutat
July 2025
Pediatric I, Center for Pediatric and Adolescent Medicine, Medical Faculty of Heidelberg, Heidelberg, Germany.
SLC35A1-CDG is a very rare type of congenital disorders of glycosylation (CDG) with only five cases known to date. Here, we review the literature and present new data from a sixth patient carrying the uncharacterized variant c.133A>G; p.
View Article and Find Full Text PDFSci Rep
July 2025
Department of Genetics and Biochemistry, Center for Human Genetics, Clemson University, Clemson, USA.
Alternative polyadenylation results in different 3' isoforms of messenger RNA (mRNA) transcripts. Alternative polyadenylation in the 3' untranslated region (3'UTR) can alter RNA localization, stability and translational efficiency. The SERPINA1 mRNA has two distinct 3' UTR isoforms, both of which express the protease inhibitor α-1-antitrypsin (A1AT).
View Article and Find Full Text PDF